United States - English - NLM (National Library of Medicine)

pacific pharma, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium solution is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli , staphylococcus  aureus , streptococcus  pneumoniae , streptococcus (viridans group), haemophilus  influenzae , klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia  marcescens and pseudomonas  aeruginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. sulfacetamide sodium solution is contraindicated in individuals who have a hypersensitivity to sulfonamides or to any ingredient of the preparation.

United States - English - NLM (National Library of Medicine)

e. fougera & co., a division of nycomed us inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 g - sodium sulfacetamide medicated pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide medicated pads are contraindicated in persons with known or suspected hypersensitivity to sulfonamides or to any of the ingredients of the preparation. sodium sulfacetamide medicated pads are not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - indications and usage: sodium sulfacetamide 10% cleansing gel is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). it also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. contraindications: sodium sulfacetamide 10% cleansing gel is contraindicated in persons with known or suspected hypersensitivity to sulfonamides or to any of the ingredients of the product. pediatric use: safety and effectiveness in children under the age of 12 years has not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 ml - sodium sulfacetamide 10% wash is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). it is also indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides. sodium sulfacetamide 10% wash is contraindicated for use by patients having known hypersensitivity to sulfonamides or any other component of this product. safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

bi-coastal pharma international llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - sodium sulfacetamide 10% and sulfur 2% cleanser is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 10% and sulfur 2% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% and sulfur 2% cleanser is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 9 mg in 1 g - indications: sodium sulfacetamide 9% - sulfur 4.5% wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 9% - sulfur 4.5% wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 9% - sulfur 4.5% wash is not to be used by patients with kidney disease.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 10 mg in 1 g - indications: sodium sulfacetamide 10% - sulfur 5% cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% - sulfur 5% cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sodium sulfacetamide 10% - sulfur 5% cleanser is not to be used by patients with kidney disease. pediatric use: safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 80 mg in 1 ml - sodium sulfacetamide 8% - sulfur 4% topical suspension is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sodium sulfacetamide 8% - sulfur 4% topical suspension is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 8% - sulfur 4% topical suspension is not to be used by patients with kidney disease. safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 10 g in 100 g - indications: sodium sulfacetamide 10% - sulfur 4% cleansing pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 10% - sulfur 4% cleansing pads are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 10% - sulfur 4% cleansing pads are not to be used by patients with kidney disease. pediatric use: safety and effectiveness in children under the age of 12 have not been established.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals - sulfacetamide (unii: 4965g3j0f5) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide 90 mg in 473.2 ml - indications: sodium sulfacetamide 9% - sulfur 4% wash is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. contraindications: sodium sulfacetamide 9% - sulfur 4% wash is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or ony other component of this preparation. sodium sulfacetamide 9% - sulfur 4% wash is not to be used by patients with kidney disease. pediatric use: safety and effectiveness in children under the age of 12 have not been established.